The RTS, S malaria vaccine was recently recommended for use among children at risk in
malaria endemic regions. Although significant efforts have been made to minimise malaria …

RTS, S is the world's most advanced malaria vaccine candidate and is intended to protect
infants and young children living in malaria endemic areas of sub‐Saharan Africa against …

Background An ongoing phase 3 study of the efficacy, safety, and immunogenicity of
candidate malaria vaccine RTS, S/AS01 is being conducted in seven African countries …

Résumé Le vaccin antipaludique RTS, S/AS01 a reçu un avis scientifique favorable de
l'Agence Européenne des Médicaments (EMA) en Juillet 2015. L'Organisation Mondiale de …

RTS, S is the most advanced candidate vaccine against human malaria. During its
remarkable journey from conception and design in the early 1980s to the multicenter Phase …

Abstract Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative
are working in partnership to develop a malaria vaccine to protect infants and children living …

BACKGROUND: An ongoing phase 3 study of the efficacy, safety, and immunogenicity of
candidate malaria vaccine RTS, S/AS01 is being conducted in seven African countries …

On Oct 6, WHO announced that it will be recommending widespread use of the RTS, S/AS01
(RTS, S) malaria vaccine for children in sub-Saharan Africa and in other regions with …

Methods This was a phase 3 double-blind trial of the RTS, S/AS01 vaccine which is directed
against the pre-erythrocytic stage of Plasmodium falciparum malaria. It was conducted in 11 …

First proven malaria vaccine rolled out in Africa -- but doubts linger - Document - Gale
Academic OneFile Use this link to get back to this page. Copy Skip to Content Library Menu …